Stock detail

Iqvia (IQV) stock price, chart, and key data

View Iqvia stock price, chart movement, and headline metrics on Woodstock's stock detail page.

IQV

Stock detail

Iqvia

IQV · XNYS

-$18.28 (-8.73%) past day

$191.03

Overnight $189.16 (-0.98%)

XNYS24/5 tradingLast updated: Jul 25, 01:01 PM

Key metrics

Financials

Quarterly revenue, profitability, and balance-sheet snapshot

4.4B3.5B2.6B1.7B872.8M0
2025 Q2Q3Q42026 Q1
RevenueNet income

Day range

$201.74 - $215.30

Close price

$207.32

Market cap

$34.6B

P/E ratio

118.65

About the company

IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Analyst rating summary

A current read on analyst sentiment from the insight feed.

Mean target

$224

Current price $208
Low$200High$249

12

Buy

/ 13

Recent calls

07/13/2026

Mizuho Securities

Ann Hynes

Buy · Price target $230

07/10/2026

Morgan Stanley

Kallum Titchmarsh

Hold · Price target $200

07/08/2026

RBC Capital

Ryan Halsted

Buy · Price target $221

Ticker holders

Review politician disclosures and insider transactions in tabs.

Holder directory

Select a heading to reorder by name, activity date, buy/sell, or displayed value.

9/9

#1Kevin Hern

republican · House · OK-1

joint
  • Sell$50,001 / $75,001 / $100,000
$50,001/$75,001/$100,000

#2Ro Khanna

democrat · House · CA-17

child
  • Buy$1,001 / $8,001 / $15,000
  • Buy$1,000 / $8,000 / $15,000
  • Sell$1,000 / $8,000 / $15,000
  • Sell$1,000 / $8,000 / $15,000
$4,001/$32,001/$60,000

#3Markwayne Mullin

republican · Executive · OK

joint
  • Buy$15,001 / $32,501 / $50,000
308/142/474

#4Rob Bresnahan

republican · House · PA-8

self
  • Sell$1,001 / $8,001 / $15,000
  • Buy$15,001 / $32,501 / $50,000
167/96/239

#5Ro Khanna

democrat · House · CA-17

spouse
  • Buy$1,000 / $8,000 / $15,000
111/13/208

#6Kevin Hern

republican · House · OK-1

self
2024
40/5/76

#7Donald J Trump

republican · Executive

self
2026
39/4/73

#8Diana Harshbarger

republican · House · TN-1

self
2023
39/4/73

#9John Boozman

republican · Senate · AR

joint
  • Sell$1,001 / $8,001 / $15,000
35/4/66

Market action

A concise summary of the latest filing, transaction, or market-moving item.

IQVIA Holdings Inc. reported an insider ownership update for Leslie Wims Morris in a Form 4 filed on July 16, 2026, covering an event dated July 14, 2026. Morris is identified as the reporting person, and the filing relates to derivative securities tied to IQVIA common stock, specifically deferred shares. The filing’s explanatory note states that each deferred share is convertible into one share of IQVIA Holdings Inc. common stock upon settlement. These deferred shares are governed by the company’s Non-Employee Director Deferral Plan, indicating the securities are connected to director compensation deferral arrangements rather than necessarily representing an open-market stock purchase or sale. Under the plan terms described in the filing, the deferred shares become settleable when Morris ceases to serve as a director, upon a change in control of IQVIA, or upon Morris’s death. The securities have no expiration date. That makes them economically linked to IQVIA common stock on a one-for-one basis, but settlement is delayed until one of the specified triggering events occurs. The document text provided does not include the Form 4 transaction table details that would normally show the transaction code, number of deferred shares acquired or disposed of, transaction price, or the exact number of derivative securities beneficially owned after the reported transaction. As a result, the filing clearly reports an ownership change involving deferred shares, but the excerpt does not disclose the specific share count, price, or transaction code needed to quantify the change. The filing was signed on Morris’s behalf by Abigail Jeck as attorney-in-fact under a power of attorney. For investors, the key point is that IQVIA disclosed a director-related change in deferred equity ownership, with the reported securities ultimately convertible into common stock, but settlement deferred under the company’s non-employee director plan.

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

Contact via LINE

Scan the QR code to get started

LINE QR Code